SEC Form 4 · accession 0000899243-19-000294
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seymour Liebman
Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2019 | M | 9,708 | — | A | 27,708 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 1, 2019 | A | 13,289 | A | — | — | Common Stock | 13,289 | 13,289 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 1, 2019 | M | 9,708 | A | — | — | Common Stock | 9,708 | 9,708 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2020.
- F3On January 1, 2018 the reporting person was granted 9,708 restricted stock units that vested on January 1, 2019.